These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 34516670

  • 1. Comparison between 18 F-DCFPyL PET and MRI for the detection of transition zone prostate cancer.
    Liu Y, Dong Y, Liu J, Zhang X, Lin M, Xu B.
    Prostate; 2021 Dec; 81(16):1329-1336. PubMed ID: 34516670
    [Abstract] [Full Text] [Related]

  • 2. Enhancing prostate cancer diagnosis and reducing unnecessary biopsies with [18F]DCFPyL PET/CT imaging in PI-RADS 3/4 patients.
    Fu Y, Zhao M, Chen J, Wen Q, Chen B.
    Sci Rep; 2024 Jul 05; 14(1):15525. PubMed ID: 38969741
    [Abstract] [Full Text] [Related]

  • 3. Prospective Comparison of PET Imaging with PSMA-Targeted 18F-DCFPyL Versus Na18F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer.
    Rowe SP, Li X, Trock BJ, Werner RA, Frey S, DiGianvittorio M, Bleiler JK, Reyes DK, Abdallah R, Pienta KJ, Gorin MA, Pomper MG.
    J Nucl Med; 2020 Feb 05; 61(2):183-188. PubMed ID: 31451492
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic Accuracy and Interobserver Agreement of PI-RADS Version 2 and Version 2.1 for the Detection of Transition Zone Prostate Cancers.
    Wei CG, Zhang YY, Pan P, Chen T, Yu HC, Dai GC, Tu J, Yang S, Zhao WL, Shen JK.
    AJR Am J Roentgenol; 2021 May 05; 216(5):1247-1256. PubMed ID: 32755220
    [Abstract] [Full Text] [Related]

  • 7. Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on 18F-DCFPyL PET/CT Imaging.
    Werner RA, Bundschuh RA, Bundschuh L, Javadi MS, Leal JP, Higuchi T, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Lapa C, Rowe SP.
    J Nucl Med; 2018 Dec 05; 59(12):1857-1864. PubMed ID: 30190304
    [Abstract] [Full Text] [Related]

  • 8. Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial.
    Bodar YJL, Jansen BHE, van der Voorn JP, Zwezerijnen GJC, Meijer D, Nieuwenhuijzen JA, Boellaard R, Hendrikse NH, Hoekstra OS, van Moorselaar RJA, Oprea-Lager DE, Vis AN.
    World J Urol; 2021 Jul 05; 39(7):2439-2446. PubMed ID: 33079250
    [Abstract] [Full Text] [Related]

  • 9. Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer.
    Tamada T, Kido A, Takeuchi M, Yamamoto A, Miyaji Y, Kanomata N, Sone T.
    Eur J Radiol; 2019 Dec 05; 121():108704. PubMed ID: 31669798
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ Uptake.
    Li X, Rowe SP, Leal JP, Gorin MA, Allaf ME, Ross AE, Pienta KJ, Lodge MA, Pomper MG.
    J Nucl Med; 2017 Jun 05; 58(6):942-946. PubMed ID: 27932557
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted ¹⁸F-DCFPyL PET/CT.
    Rowe SP, Gorin MA, Hammers HJ, Som Javadi M, Hawasli H, Szabo Z, Cho SY, Pomper MG, Allaf ME.
    Ann Nucl Med; 2015 Dec 05; 29(10):877-82. PubMed ID: 26286635
    [Abstract] [Full Text] [Related]

  • 17. Head-to-head comparison of PI-RADS v2 and PI-RADS v1.
    Polanec S, Helbich TH, Bickel H, Pinker-Domenig K, Georg D, Shariat SF, Aulitzky W, Susani M, Baltzer PA.
    Eur J Radiol; 2016 Jun 05; 85(6):1125-31. PubMed ID: 27161062
    [Abstract] [Full Text] [Related]

  • 18. Prostate-specific membrane antigen PET/MRI validation of MR textural analysis for detection of transition zone prostate cancer.
    Bates A, Miles K.
    Eur Radiol; 2017 Dec 05; 27(12):5290-5298. PubMed ID: 28608163
    [Abstract] [Full Text] [Related]

  • 19. Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study.
    Bodar YJL, Zwezerijnen BGJC, van der Voorn PJ, Jansen BHE, Smit RS, Kol SQ, Meijer D, de Bie K, Yaqub M, Windhorst BAD, Hendrikse HNH, Vis AN, Oprea-Lager DE.
    Eur J Nucl Med Mol Imaging; 2022 Apr 05; 49(5):1731-1742. PubMed ID: 34725727
    [Abstract] [Full Text] [Related]

  • 20. A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).
    Pienta KJ, Gorin MA, Rowe SP, Carroll PR, Pouliot F, Probst S, Saperstein L, Preston MA, Alva AS, Patnaik A, Durack JC, Stambler N, Lin T, Jensen J, Wong V, Siegel BA, Morris MJ.
    J Urol; 2021 Jul 05; 206(1):52-61. PubMed ID: 33634707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.